PMS Premenstrual Syndrome
PMS Premenstrual Syndrome


PMS: Could suppressing my cycle improve my PMS?

Home
What's New - Blog
Abortion
Amenorrhoea - Absent Periods
Birth Control
Bladder Symptoms
Cancer in Women
Diet / Weight Loss
Dysmenorrhoea
Ectopic Pregnancy
Endometriosis
Female Sexual Problems
Fibroids
HRT Risks & Benefits
Hysterectomy
Infections
Infertility
Medication - Drugs
Menopause
Menorrhagia Heavy Periods
Miscarriage
Painful Sex - Dyspareunia
Pap Smear Test
PCOS
Pelvic Pain
PMS- Premenstrual Syndrome
Pregnancy & Childbirth
Vaginal Discharge
Vaginal Prolapse
Viagra, Libido and Sex Drive.
The Author
Consultations
Contact Us

Authors:

Murray SC. Muse KN.

Institution:

Dr. S.C. Murray, Department of Obstetrics/Gynecology, University of Kentucky, 800 Rose Street, Lexington, KY 40536-0084; United States. E-Mail: murrays@pop.uky.edu.

Title:

Effective treatment of severe menstrual migraine headaches with gonadotropin-releasing hormone agonist and 'add-back' therapy (1997-2025).

Source:

Fertility and Sterility. Vol 67(2) (pp90-393), 1997.

Abstract:

Objectives:

To determine the efficacy of treating women with severe menstrual migraine headaches with GnRH agonist (GnRH-a) therapy, alone and combined with continuous estrogen-progestin 'add-back.'

Design:

Nonrandomized, prospective treatment study.

Setting:

Outpatient clinic in a university medical center.

Patients:

Five women who had repetitive, severe, migraine headaches limited to the perimenstrual period were selected carefully.

Interventions:


After 2 months of basal evaluation, all subjects received GnRH-a (leuprolide acetate depot formulation, 3.75 mg IM, monthly) for 10 months. Beginning with the 5th month, 'add-back' therapy (the addition of transdermal E2, 0.1 mg daily, and oral medroxyprogesterone acetate, 2.5 mg daily) was initiated.

Main Outcome Measure(s):

Patients rated headache severity from 0 (absent) to 3 (severe) each day; these were combined each month to obtain a cumulative score for that month. In addition, patients were asked their overall assessment of the treatments.

Results:

The mean headache scores for the GnRH-a treatment months (4.0 +/- 1.5, mean +/- SEM) and for the GnRH-a and 'add-back' treatment months (3.1 +/- 0.7) were each significantly lower than those of the control months (15.3 +/- 24). The patients uniformly found both treatments to be well tolerated and near- curative for their condition.

Conclusion(s):

Gonadotropin-releasing hormone agonist administration, alone or with 'add-back' therapy, is a very effective treatment for carefully selected patients with severe, perimenstrual migraine headaches.


Back Home Up Next

Please click on the required question.

Do you have an unanswered women's health question?

Please let us have your general question on our NEW FORUM / MESSAGE BOARDS facility and we will try to answer it for you. I am sure that you will appreciate that we cannot offer advice on the management of an individual's specific problem.


Thank you for your visiting us at 2WomensHealth.com.

This is the personal website of David A Viniker MD FRCOG, Consultant Obstetrician and Gynaecologist at Whipps Cross University Hospital, London.

I do hope that you find the answers to your questions in the patient information and medical advice provided. If you still have unanswered questions, please consider entering them into one of our forums and I will try to assist you.

DISCLAIMER

The aim of this web site is to provide a general guide and it is not intended as a substitute for a consultation with an appropriate specialist in respect of individual care and treatment.

PMS Premenstrual Syndrome

?